Prevention of transgene silencing during human pluripotent stem cell differentiation
Cell Stem Cell · 2026-03 · 33 (3) · 517-530.e8
DOI: 10.1016/j.stem.2026.01.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stem Cell, 2026-03. Verfasst von Takeshi Uenaka und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Pathology, St…. Hauptthemen laut MEDLINE: Cell Differentiation, Transgenes, Pluripotent Stem Cells, Gene Silencing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute on Aging, New York Stem Cell Foundation, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; The Phi…
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Departm…
- National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA.
- Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.
- German Center for Neurodegenerative Diseases (DZNE) Tübingen, and Hertie Institute for Clinical Brain Research, Department of Cellular Neurology, University of Tübingen, 72076 Tübingen, Germany.
Förderung
- National Institute on Aging
- New York Stem Cell Foundation
- National Institute of Neurological Disorders and Stroke
- Wellcome
- National Institutes of Health
- Wellcome Trust
- Wu Tsai Neurosciences Institute, Stanford University
- Stanford University
Zitieren
APA
Uenaka, T., Napole, A., Saha, A. D., Sun, D., Singavarapu, A., Calzada, E., Chen, J., Erlebach, L., McQuade, A., Ramos, D. M., Rigamonti, A., Salazar, L., Samelson, A. J., Sedov, K., Welsh, N. J., Wild, K., Wu, Q., Arenas, E., Bassett, A. R., …, & Wernig, M. (2026). Prevention of transgene silencing during human pluripotent stem cell differentiation. Cell Stem Cell, 33(3), 517-530.e8. https://doi.org/10.1016/j.stem.2026.01.007
Vancouver
Uenaka T, Napole A, Saha AD, Sun D, Singavarapu A, Calzada E, et al. Prevention of transgene silencing during human pluripotent stem cell differentiation. Cell Stem Cell. 2026;33(3):517-530.e8. doi:10.1016/j.stem.2026.01.007
BibTeX
@article{Uenaka2026,
author = {Uenaka, Takeshi and Napole, Alan and Saha, Aninda Dibya and Sun, Duo and Singavarapu, Angelina and Calzada, Elizabeth and Chen, Jiahui and Erlebach, Lena and McQuade, Amanda and Ramos, Daniel M and Rigamonti, Alessandra and Salazar, Lisa and Samelson, Avi J and Sedov, Kamilla and Welsh, Natalie J and Wild, Katleen and Wu, Qianxin and Arenas, Ernest and Bassett, Andrew R and Kampmann, Martin and Kronenberg-Versteeg, Deborah and Merkle, Florian T and Schüle, Birgitt and Thompson, Leslie M and Skarnes, William C and Ward, Michael E and Wernig, Marius},
title = {Prevention of transgene silencing during human pluripotent stem cell differentiation},
journal = {Cell Stem Cell},
year = {2026},
volume = {33},
number = {3},
pages = {517--530.e8},
doi = {10.1016/j.stem.2026.01.007}
}
EUVIMED